What drugs does ZEALAND PHARMA make?

ZEALAND PHARMA has 2 FDA-approved drugs including ZEGALOGUE, ZEGALOGUE (AUTOINJECTOR).

What therapeutic areas does ZEALAND PHARMA focus on?

ZEALAND PHARMA focuses primarily on Metabolic.

← Back

Data updated: Mar 10, 2026

ZEALAND PHARMA

Metabolic

Pharma

ZEALAND PHARMA is a pharmaceutical company focused on Metabolic. Key products include ZEGALOGUE.

2021

Since

Drugs

Trials

Approved (2yr)

Key Drugs

ZEGALOGUE

dasiglucagon hydrochloride

Metabolic

Glucagon receptor 2 indications · 2021

ZEGALOGUE (AUTOINJECTOR)

dasiglucagon hydrochloride

· 2021

Recent Activity

No recent activity

SEC Filings ProEarly access

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Metabolic 100%

1 drugs Phase 3: 5 Phase 2: 4 Phase 1: 2

Pipeline Strength ProEarly access

Competitors ProEarly access

Merck big-pharma

Metabolic

Johnson & Johnson big-pharma

Metabolic

OTSUKA ICU MEDCL specialty

ZEALAND PHARMA

Key Drugs

Recent Activity

Therapeutic Focus

Pipeline Strength ProEarly access

Competitors ProEarly access

All Drugs (2)

Active (2)

Discontinued (0)

Company Info